Literature DB >> 8899090

Clinical response after transjugular intrahepatic portosystemic stent shunt insertion for refractory ascites in cirrhosis.

E H Forrest1, A J Stanley, D N Redhead, A J McGilchrist, P C Hayes.   

Abstract

BACKGROUND: Transjugular intrahepatic portosystemic stent shunts (TIPSS) have been used successfully to reduce portal pressure in the context of variceal haemorrhage. Recent interest has focused on the possible use of TIPSS to manage refractory ascites. AIM: To study the effect of TIPSS insertion in 18 patients with refractory ascites.
RESULTS: Response rates were 33.3%, 50%, 33.3% and 26.7% at 1 week, 4 weeks, 3 months and 6 months, respectively. Overall mortality was 50% with a new or worsening encephalopathy rate also of 50%. Patients with lower serum bilirubin and serum creatinine prior to TIPSS insertion had greater response at 1 and 4 weeks, respectively. There was no improvement in either liver or renal function after TIPSS insertion by standard laboratory tests, although serum sodium increased in the responders after 1 month.
CONCLUSION: TIPSS improves refractory ascites in only a minority of patients, and is associated with high encephalopathy and mortality rates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8899090     DOI: 10.1046/j.1365-2036.1996.60202000.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

Review 1.  TIPSS 10 years on.

Authors:  R Jalan; H F Lui; D N Redhead; P C Hayes
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 2.  Transjugular portosystemic stent shunt in treatment of liver diseases.

Authors:  M Schepke; T Sauerbruch
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

3.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

5.  Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.

Authors:  Hauke S Heinzow; Philipp Lenz; Michael Köhler; Frank Reinecke; Hansjörg Ullerich; Wolfram Domschke; Dirk Domagk; Tobias Meister
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742

Review 6.  Evaluation and management of patients with refractory ascites.

Authors:  Bahaa Eldeen Senousy; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

7.  Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.

Authors:  Dengke Teng; Hao Zuo; Lin Liu; Jinghui Dong; Lei Ding
Journal:  Virol J       Date:  2018-10-01       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.